Email
Location
- Proof of Concept (2024) — UniCardioMab: Universal Cardiac Mesoangioblasts for treating DMD Dilated Cardiomyopathy
- Proof of Concept (2023) — MABank: Creation of a GLP bank of immune-privileged, immortal mesoangioblasts to treat monogenic, recessive diseases of muscle and connective tissue
- Advanced (2019) — UniMab: Immune-privileged, immortal, myogenic stem cells for gene therapy of Muscular Dystrophy.
- Advanced (2008) — Stem cells for DMD: Novel strategies for the cell therapy of muscular dystrophies